Inhibrx Biosciences (INBX) Research & Development (2023 - 2025)
Historic Research & Development for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $28.5 million.
- Inhibrx Biosciences' Research & Development fell 2663.2% to $28.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.0 million, marking a year-over-year decrease of 5205.47%. This contributed to the annual value of $203.7 million for FY2024, which is 631.55% up from last year.
- Per Inhibrx Biosciences' latest filing, its Research & Development stood at $28.5 million for Q3 2025, which was down 2663.2% from $22.3 million recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Research & Development ranged from a high of $82.1 million in Q4 2023 and a low of $22.3 million during Q2 2025
- For the 3-year period, Inhibrx Biosciences' Research & Development averaged around $44.6 million, with its median value being $37.5 million (2023).
- In the last 5 years, Inhibrx Biosciences' Research & Development skyrocketed by 9829.94% in 2024 and then tumbled by 6707.62% in 2025.
- Quarter analysis of 3 years shows Inhibrx Biosciences' Research & Development stood at $82.1 million in 2023, then crashed by 59.35% to $33.4 million in 2024, then decreased by 14.48% to $28.5 million in 2025.
- Its Research & Development stands at $28.5 million for Q3 2025, versus $22.3 million for Q2 2025 and $36.9 million for Q1 2025.